Pharmac to broaden access to four diabetes medicines from September
Pharmac is expanding eligibility for four funded diabetes medicines, expecting to benefit over 30,000 people within five years.
Pharmac will expand eligibility for four funded diabetes medicines starting in September. The broadened access is expected to benefit more than 30,000 people over the next five years.
Covered byStuffNot covered byRNZNZ Herald1NewsNewstalk ZBOtago Daily TimesNewsroomThe SpinoffBusinessDeskinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
Stuff
30,000 set to benefit as Pharmac broadens diabetes medicine access
Eligibility for four funded medicines will expand from September, with Pharmac expecting more than 30,000 people to benefit over five years.